Anti-mediator complex subunit 13L Antibody Products

Anti-mediator complex subunit 13L antibodies are used for the immunodetection of the protein encoded by the MED13L gene. In humans, the canonical protein has a reported length of 2210 amino acid residues and a mass of 242.6 kDa. Its subcellular localization is in the nucleus. It is reported to be highly expressed in the brain (cerebellum), heart (aorta), skeletal muscle, kidney, placenta and peripheral blood leukocytes. A member of the Mediator complex subunit 13 protein family, it is a known component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. The gene encoding this protein is implicated in Impaired intellectual development and distinctive facial features with or without cardiac defects. Other names for this target antigen include PROSIT240, THRAP2, TRAP240L, mediator of RNA polymerase II transcription subunit 13-like, and MRFACD. Gene orthologs have been identified in the mouse, rat, bovine, frog, chimpanzee and chicken species.

Anti-mediator complex subunit 13L Antibody Products

Your search terms and filters produced no results.

Please use the Antibodies search tool above to find what you're looking for.

Suggested Products

  • S-RMab® Tau (pT217) IVD Antibody Pair – Precision Markers for Alzheimer’s Detection

    The S-RMab® Tau (pT217) IVD antibody pair (Capture S0B3533; Detector S0B3059) provides a powerful solution for Alzheimer’s disease research and clinical diagnostics. Developed using AntBio’s proprietary Single B-Cell and recombinant technologies, these antibodies demonstrate superior affinity, minimal batch variability, and outstanding stability for precise detection of Tau phosphorylated at threonine-217—a key neurodegenerative biomarker. Ideal for ELISA, CLIA, and other immunodiagnostic ...
  • KRAS Related Products

    KRAS is one of the most frequently mutated oncogenes in human cancers, playing a critical role in tumor initiation, progression, and therapeutic resistance. Mutations such as KRAS G12C, G12D, G12V, and G13D are commonly observed in lung, colorectal, and pancreatic cancers, making KRAS a high-value but historically challenging drug target. TargetMol provides KRAS-related products, including a comprehensive range of small-molecule inhibitors, biochemical tools, and research reagents designed to ...
  • <<
  • >>

Recent Product Review

Guided Browse

Browse Antibodies by Antigen

Browse Antibodies by Clone